Allscripts Healthcare Solutions Inc (MDRX):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Allscripts Healthcare Solutions Inc (MDRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10067
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Allscripts Healthcare Solutions Inc (Allscripts), formerly Allscripts-Misys Healthcare Solutions, Inc., is a provider of healthcare information technology solutions. The company’s major solutions include Electronic Health Records (EHR), Financial Management Solutions, Population Health Management solutions, and Precision Medicine/Consumer Solutions. The company also offers services such as consulting services, managed IT services, education, hardware and hosting services. Allscripts caters its solutions to retail pharmacies, pharmacy benefit managers, physicians, hospitals, governments, health systems, health plans, retail clinics, and post-acute organizations. It has clients in North America, Asia, Australia, the Middle East and the UK. Allscripts is headquartered in Chicago, Illinois, the US.

Allscripts Healthcare Solutions Inc (MDRX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Allscripts Healthcare Solutions Inc, Medical Devices Deals, 2012 to YTD 2018 8
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
CarePort Health Raises USD3.8 Million in Venture Financing 10
Partnerships 11
Quintiles Transnational Enters Into Co-Development Agreement With Allscripts Healthcare Solutions 11
Acquisition 12
Allscripts Healthcare Acquires Oasis Medical Solutions 12
Allscripts Healthcare Solutions Inc – Key Competitors 13
Allscripts Healthcare Solutions Inc – Key Employees 14
Allscripts Healthcare Solutions Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 18
Financial Announcements 18
Nov 01, 2018: Allscripts announces third quarter 2018 results 18
Aug 02, 2018: Allscripts announces second quarter 2018 results 20
Feb 16, 2017: Allscripts announces fourth quarter and 2016 full-year results 22
Jan 09, 2017: Allscripts announces record fourth quarter bookings and strong finish to 2016 26
Corporate Communications 27
Sep 06, 2017: Surescripts and Allscripts Join Forces to Make Patient Medication History Data Available to Pharmacists in the Wake of Hurricane Harvey 27
Government and Public Interest 29
Oct 30, 2018: First-ever Chicago-Israel Health Tech summit opens door to U.S. market for 20 of Israel’s most promising health tech startups 29
Jan 30, 2017: Allscripts open ecosystem enables more than 2 billion data shares, continues to lead industry in innovation, data sharing and connectivity 30
Product News 31
Nov 15, 2017: Allscripts to deliver anesthesiology solution at the Royal Adelaide Hospital 31
Apr 26, 2017: Concentra to launch Allscripts Practice Management for optimal efficiency and productivity 32
Other Significant Developments 33
Aug 13, 2018: Allscripts open ecosystem drives healthcare data interoperability 33
Sep 20, 2017: PainCAS now available for Allscripts users: A pain and opioid risk assessment featuring SOAPP & COMM 34
Sep 14, 2017: Surescripts and Allscripts Expand Emergency Service to Make Patient Medication History Data Available to Pharmacists in the Wake of Hurricane Irma 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Allscripts Healthcare Solutions Inc, Medical Devices Deals, 2012 to YTD 2018 8
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CarePort Health Raises USD3.8 Million in Venture Financing 10
Quintiles Transnational Enters Into Co-Development Agreement With Allscripts Healthcare Solutions 11
Allscripts Healthcare Acquires Oasis Medical Solutions 12
Allscripts Healthcare Solutions Inc, Key Competitors 13
Allscripts Healthcare Solutions Inc, Key Employees 14
Allscripts Healthcare Solutions Inc, Other Locations 15
Allscripts Healthcare Solutions Inc, Subsidiaries 16

List of Figures
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Allscripts Healthcare Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Allscripts Healthcare Solutions Inc, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[Allscripts Healthcare Solutions Inc (MDRX):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SM Energy Co (SM):企業の財務・戦略的SWOT分析
    SM Energy Co (SM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Maxim Integrated Products, Inc.:企業の戦略・SWOT・財務情報
    Maxim Integrated Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Maxim Integrated Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Integra LifeSciences Holdings Corp (IART):医療機器:M&Aディール及び事業提携情報
    Summary Integra LifeSciences Holdings Corp (Integra) is a medical technology company, which offers engineered collagen-based product lines. The company’s portfolio consists of surgical instruments, advanced wound care and orthopedic hardware, specialty metal implants, dermal regeneration products, o …
  • Exide Technologies:企業の戦略的SWOT分析
    Exide Technologies - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • HTG Molecular Diagnostics Inc (HTGM):医療機器:M&Aディール及び事業提携情報
    Summary HTG Molecular Diagnostics Inc (HTG) is a technology company that provides molecular technology solutions. The company provides products such as HTG edge system, HTG edgeseq reagents and HTG edgeseq immuno-oncology biomarker panel assay, among others. It develops assays and reagent systems th …
  • ALPCO Diagnostics:医療機器:M&Aディール及び事業提携情報
    Summary ALPCO Diagnostics (ALPCO) is a life science company that imports and distributes immunoassay based products. The company offers immunoassays, chemiluminescent assays, flow cytometry reagents, purified antibodies, recombinant proteins, and HPLC and MS-MS reagents. It provides food additives, …
  • Amorepacific Corp:企業の戦略・SWOT・財務情報
    Amorepacific Corp - Strategy, SWOT and Corporate Finance Report Summary Amorepacific Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Chevron Corp (CVX):企業の財務・戦略的SWOT分析
    Chevron Corp (CVX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Coca-Cola HBC-Srbija d.o.o.:企業の戦略・SWOT・財務情報
    Coca-Cola HBC-Srbija d.o.o. - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola HBC-Srbija d.o.o. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Omnicell Inc (OMCL):企業の財務・戦略的SWOT分析
    Omnicell Inc (OMCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • SINTEF:企業の戦略的SWOT分析
    SINTEF - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Republic Services, Inc.:戦略・SWOT・企業財務分析
    Republic Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Republic Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Blueprint Medicines Corp (BPMC):企業の財務・戦略的SWOT分析
    Summary Blueprint Medicines Corp (Blueprint Medicines), formerly Hoyle Pharmaceuticals Inc, discovers and develops precision therapies for the treatment of cancers and rare diseases. The company offers AYVAKIT (avapritinib) medicine to treat gastrointestinal stromal tumor (GIST); and GAVRETO (pralse …
  • Faxitron Bioptics LLC:医療機器:M&Aディール及び事業提携情報
    Summary Faxitron Bioptics LLC (Faxitron) is a medical device company that develops cabinet x-ray systems for specimen radiography, research and NDT applications. The company offers clinical products and lifescience products. Its clinical products include pathvision, corevision, biovision, localizer, …
  • Northrop Grumman Aerospace Systems:企業の戦略・SWOT・財務情報
    Northrop Grumman Aerospace Systems - Strategy, SWOT and Corporate Finance Report Summary Northrop Grumman Aerospace Systems - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Aimmune Therapeutics Inc (AIMT):企業の財務・戦略的SWOT分析
    Summary Aimmune Therapeutics Inc (Aimmune) formerly Allergen Research Corp is a clinical-stage biopharmaceutical company that develops proprietary product candidates for the treatment of peanut and other food allergies. The company’s lead product candidate AR101 is used to treat the peanut allergy. …
  • Eastern Platinum Limited:企業の戦略・SWOT・財務情報
    Eastern Platinum Limited - Strategy, SWOT and Corporate Finance Report Summary Eastern Platinum Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Pathogenica Inc-医療機器分野:企業M&A・提携分析
    Summary Pathogenica Inc (Pathogenica) is a medical device company that offers multiplex bacterial detection and genotyping kit. The company provides medical diagnostic sequencing products and services for research and clinical use. Its scientific consulting services offers experimental design, DxSeq …
  • Cherkizovo Group OJSC (GCHE):企業の財務・戦略的SWOT分析
    Cherkizovo Group OJSC (GCHE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • MyoKardia Inc (MYOK):企業の財務・戦略的SWOT分析
    MyoKardia Inc (MYOK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆